The Schmidt Firm, LLP

New Birth Control Pills Increase Risk of Blood Clots

November 15, 2011 – Researchers have found new evidence that women who take birth control pills with drospirenone have a significantly higher risk of developing blood clots, deep vein thrombosis, and pulmonary embolism. The risk of blood clots may be 40% higher for women who take birth control pills containing the chemical drospirenone, a synthetic… Read More

Pradaxa Lawsuits

The drug Pradaxa (generic: dabigatran), prescribed to prevent strokes and atrial fibrillation, has recently caused 14 deaths in Japan, and as many as 260 deaths worldwide. More specifically, Pradaxa has been linked to a number of severe, life-threatening cases of internal bleeding, particularly in the elderly. What You Can Do & How We Can Help… Read More

Sprycel Lawsuits

October 11, 2011 — The leukemia drug Sprycel (generic: dasatinib) may increase the chances of pulmonary arterial hypertension (PAH), a rare but serious condition causing high blood pressure in the lungs, the FDA says. Serious side effects of PAH may include chest pain, body swelling and even possible death. What You Can Do & How… Read More

Avastin Warning Label to Include Risks of Blood Clot, Ovarian Failure and Jaw Deterioration

The cancer medication Avastin is linked to a number of adverse events, the FDA says, necessitating a change to the drug’s label. September 30, 2011 — New warnings were added to the label of bevacizumab, more commonly known as name brand Avastin, after scientific research suggested Avastin patients were at an increased risk of ovarian… Read More

Diflucan Lawsuits

August 3, 2011 — Long term and high dose use of the antifungal medication Diflucan (fluconazole) may cause a rare and distinct set of birth defects in infants born to mothers who were treated with the drug during the first trimester of pregnancy. What You Can Do & How We Can Help The Schmidt Firm,… Read More

FDA Concerned with Birth Control Blood Clot Risk

September 26, 2011 — The FDA has completed a review of two 2011 studies looking at the risk of blood clots for women using drospirenone-containing birth control pills. While it has not reached a formal conclusion, the FDA says there is reason for concern, prompting a joint meeting of two FDA committees to discuss the… Read More

European Agency Limits Access To Multaq

The Wall Street Journal September 22, 2011 — After linking Multaq (generic: dronedarone) with increased risks of life-threatening liver and lung injury, a European regulation group is limiting use of the heart-rhythm drug for safety reasons. According to experts, the U.S. Food and Drug Administration (FDA) is expected to follow suit in upcoming weeks. The… Read More

Actos and Cancer

Actos (generic: pioglitzazone), a popular blood sugar lowering medication prescribed to people suffering from Type 2 diabetes, puts patients at an increased risk of cancer, the FDA says. When taken for at least one year and at high doses, Actos can lead to bladder cancer. What You Can Do & How We Can Help The… Read More

Brazilian Blowout Lawsuits

August 22, 2011 — Today the FDA sent a scathing letter to Brazilian Blowout maker GIB LLC, warning the agency it had found evidence the smoothing solution contained formaldehyde, a known cancer-causing chemical, which can seriously harm customers and stylists. More so, the FDA found Brazilian Blowout products to be misbranded and misleading. The products… Read More

Zofran Lawsuits

September 15, 2011 — The FDA issued a Drug Safety Communication alerting the medical community to the risk of abnormal heart rhythm associated with the anti-nausea medication Zofran (generic: ondansetron or ondansetron hydrochoride). In some cases, the abnormal heart rhythm can become severe, leading to conditions such as Torsade de Pointes, which may be lethal…. Read More